ArticleJournal of animal science and biotechnology2026
Synthesis and efficacy of tetraacetyl vitamin C ester: a novel alternative to traditional vitamin C and sodium acetate in aquafeeds.
Article in Journal of animal science and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundThe application of traditional vitamin C (VC) and sodium acetate (SA) in aquafeeds is hampered by significant limitations. VC suffers from poor stability during feed processing and storage, as well as low bioavailability. SA is highly hygroscopic, thermally unstable, and rapidly absorbed, leading to short duration of action. This study aimed to design, synthesize, and evaluate tetraacetyl vitamin C ester (TVCE), a novel VC-acetic acid conjugate, as a superior alternative.
resultsTVCE was successfully synthesized via a one-step acetylation reaction with high yield (90%) and purity (> 95%). By optimizing the distillation recovery process, the by-product acetic acid from the reaction was efficiently recovered and recycled. TVCE demonstrated excellent lipophilicity, remarkable thermal stability (withstanding 160 °C), and was efficiently hydrolyzed by pancreatic lipase in simulated intestinal fluid, indicating its function as a prodrug. In zebrafish, TVCE enhanced systemic antioxidant capacity (increasing superoxide dismutase activity and total antioxidant capacity, while decreasing malondialdehyde content) comparably or superiorly to sodium VC-2-phosphate, even at a lower VC-equivalent dosage. In tilapia, dietary inclusion of TVCE, particularly at 0.1%, significantly improved the weight gain rate and survival rate (P < 0.05). Notably, despite providing only 48% of the acetate equivalent found in the physical mixture (sodium VC-2-phosphate + SA) group, TVCE still demonstrated superior performance. Furthermore, TVCE supplementation ameliorated liver and intestinal health, as evidenced by reduced serum alanine aminotransferase, diamine oxidase levels, and liver total triglyceride levels, improved tissue morphology, and an optimized gut microbiota structure characterized by an increased abundance of Bacteroidota.
conclusionsTVCE is successfully synthesized through a simple, green, and environmentally friendly process, which has successfully achieved the co-production of TVCE and acetic acid. TVCE effectively overcomes the stability and bioavailability issues of conventional VC and SA. In vivo studies demonstrated that TVCE significantly enhances growth performance, antioxidant status, and liver-intestine health in fish. These benefits are attributed to the synergistic effects of VC and acetic acid released upon hydrolysis, which results in a higher biological titer and achieving a "1 + 1 > 2" outcome. These findings establish TVCE as a promising multi-functional nutritional precursor with significant application potential in aquatic feeds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.